Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Combination Lymphoma Immunotherapy Using Checkpoint Blockade and Intratumoral Virus-like Particles Containing CpG TLR9 Agonist

Caitlin D Lemke, PhD, Sue E Blackwell, MS, Arthur M Krieg, MD, Aliasger Salem, PhD, George J Weiner, MD

Blood (2016) 128 (22): 3023.

https://doi.org/10.1182/blood.V128.22.3023.3023

Published: 2016

Journal Articles

Novel IL-2Ralpha (CD25)-Binding RNA Aptamer to Target T Regulatory Cells

Suresh Veeramani, DVM, PhD, Sue E Blackwell, MS, William H Thiel, PhD, Paloma H Giangrande, PhD, George J Weiner, MD

Blood (2016) 128 (22): 3697.

https://doi.org/10.1182/blood.V128.22.3697.3697

Published: 2016

Journal Articles

Three Steps to Breaking Immune Tolerance: A Microparticle Approach

Amani Makkouk, MS, Vijaya B Joshi, PhD, Caitlin D Lemke, PhD, Amaraporn Wongrakpanich, BS, Alicia K Olivier, DVM, PhD, Sue E Blackwell, MS, Aliasger K Salem, PhD, George J. Weiner, MD

Blood (2014) 124 (21): 4504.

https://doi.org/10.1182/blood.V124.21.4504.4504

Published: 2014

Journal Articles

Induction of a CTL-Like Phenotype In B-CLL Cells Stimulated with Interleukin 21 and CpG Oligodeoxynucleotides

Bernd Jahrsdoerfer, MD, Sue E Blackwell, Magdalena Hagn, MD, Verena Ebel, Thamara Beyer, Kai Sontheimer, Karen Dahlke, George Weiner, MD, Thomas Simmet, MD

Blood (2010) 116 (21): 3906.

https://doi.org/10.1182/blood.V116.21.3906.3906

Published: 2010

Journal Articles

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion

Bernd Jahrsdörfer, Angelika Vollmer, Sue E. Blackwell, Julia Maier, Kai Sontheimer, Thamara Beyer, Birgit Mandel, Oleg Lunov, Kyrylo Tron, G. Ulrich Nienhaus, Thomas Simmet, Klaus-Michael Debatin, George J. Weiner, Dorit Fabricius

Blood (2010) 115 (6): 1156–1165.

https://doi.org/10.1182/blood-2009-07-235382

Published: 2010

Includes: Multimedia, Supplemental data

Journal Articles

Stimulation of B-CLL Cells with Interleukin 21 and Toll Like Receptor Agonists Induces a CTL-Like Transcriptional Profile.

Magdalena Hagn, MD, Verena Ebel, Kai Sontheimer, Thamara Beyer, Sue E. Blackwell, Thomas Simmet, MD, George J. Weiner, MD, Bernd Jahrsdoerfer, MD

Blood (2009) 114 (22): 3685.

https://doi.org/10.1182/blood.V114.22.3685.3685

Published: 2009

Journal Articles

Human B Cell Lines and Primary B Cells Actively Secrete Granzyme B in Response to IL-2 Family Cytokines.

Bernd Jahrsdoerfer, MD, Sue E. Blackwell, Thomas Simmet, MD, George J. Weiner, MD

Blood (2007) 110 (11): 1340.

https://doi.org/10.1182/blood.V110.11.1340.1340

Published: 2007

Journal Articles

IL-21 Plus CpG ODN Induces Granzyme B-Dependent Induction of Apoptosis in CD5-Positive B Cells Including B-CLL Cells.

Sue E. Blackwell, Bernd Jahrsdoerfer, MD, James E. Wooldridge, MD, Jian Huang, Melinda W. Andreski, Laura S. Jacobus, Christiana M. Taylor, George J. Weiner, MD

Blood (2006) 108 (11): 2823.

https://doi.org/10.1182/blood.V108.11.2823.2823

Published: 2006

Journal Articles

B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation

Bernd Jahrsdörfer, Sue E. Blackwell, James E. Wooldridge, Jian Huang, Melinda W. Andreski, Laura S. Jacobus, Christiana M. Taylor, George J. Weiner

Blood (2006) 108 (8): 2712–2719.

https://doi.org/10.1182/blood-2006-03-014001

Published: 2006

Includes: Supplemental data

Journal Articles

IL-21 and CpG ODN Are Synergistic in Their Ability To Induce Apoptosis of Chronic Lymphocytic Leukemia (CLL) Cells and Benign B1 Cells.

Bernd Jahrsdoerfer, MD, Sue E. Blackwell, James E. Wooldridge, MD, Melinda W. Andreski, Laura S. Jacobus, Christiana M. Taylor, George J. Weiner, MD

Blood (2005) 106 (11): 5022.

https://doi.org/10.1182/blood.V106.11.5022.5022

Published: 2005

Journal Articles

Cpg Oligodeoxynucleotide-Mediated Effects on B-Cell Chronic Lymphocytic Leukemia In Vitro Are Influenced by Cytogenetic Status and the Presence of Serum.

Bernd Jahrsdorfer, MD, Sue E. Blackwell, James E. Wooldridge, MD, Christiana M. Taylor, George J. Weiner, MD

Blood (2004) 104 (11): 4828.

https://doi.org/10.1182/blood.V104.11.4828.4828

Published: 2004

NARROW

Combination Lymphoma Immunotherapy Using Checkpoint Blockade and Intratumoral Virus-like Particles Containing CpG TLR9 Agonist

Novel IL-2Ralpha (CD25)-Binding RNA Aptamer to Target T Regulatory Cells

Three Steps to Breaking Immune Tolerance: A Microparticle Approach

Induction of a CTL-Like Phenotype In B-CLL Cells Stimulated with Interleukin 21 and CpG Oligodeoxynucleotides

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion

Stimulation of B-CLL Cells with Interleukin 21 and Toll Like Receptor Agonists Induces a CTL-Like Transcriptional Profile.

Human B Cell Lines and Primary B Cells Actively Secrete Granzyme B in Response to IL-2 Family Cytokines.

IL-21 Plus CpG ODN Induces Granzyme B-Dependent Induction of Apoptosis in CD5-Positive B Cells Including B-CLL Cells.

B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation

IL-21 and CpG ODN Are Synergistic in Their Ability To Induce Apoptosis of Chronic Lymphocytic Leukemia (CLL) Cells and Benign B1 Cells.

Cpg Oligodeoxynucleotide-Mediated Effects on B-Cell Chronic Lymphocytic Leukemia In Vitro Are Influenced by Cytogenetic Status and the Presence of Serum.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only